Comparison between laparoscopic complete mesocolic excision versus standard laparoscopic colonic resection for right-sided colon cancer

ISRCTN ISRCTN71842827
DOI https://doi.org/10.1186/ISRCTN71842827
Secondary identifying numbers LaCoMEStaR1
Submission date
30/03/2020
Registration date
07/04/2020
Last edited
11/08/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
A hemicolectomy is a surgical procedure that involves removing a segment of the colon, for example to treat colon cancer. The aim of this study is to compare the short-term outcomes of patients who undergo laparoscopic (keyhole surgery) right hemicolectomy using the CME and CVL technique (CME group) with patients who undergo conventional right-sided colonic resection (Not Complete Mesocolic Excision, NCME group).

Who can participate?
Patients with right-sided colon cancer who are undergoing laparoscopic colonic resection (removal of the part of the colon containing the cancer)

What does the study involve?
Participants are randomly allocated to undergo laparoscopic complete mesocolic excision with central vascular ligation (CME group) or laparoscopic standard right hemicolectomy (Not Complete Mesocolic Excision, NCME group). Both groups are followed up during their hospital stay or 30 days and long term to obtain results about ontological (cancer) outcomes.

What are the possible benefits and risks of participating?
Possible benefits include better surgical outcomes in the CME group. Possible risks include a higher rate of complications in the CME group than the NCME group.

Where is the study run from?
1. University Hospital Policlinico "P. Giaccone" of Palermo (Italy)
2. University of Palermo (Italy)

When is the study starting and how long is it expected to run for?
October 2014 to December 2022

Who is funding the study?
University of Palermo (Italy)

Who is the main contact?
1. Prof. Agrusa Antonino
2. Dr Giuseppe Di Buono
giuseppe.dibuono@unipa.it

Contact information

Dr Giuseppe Di Buono
Scientific

Via L. giuffrè, 5
Palermo
90127
Italy

ORCiD logoORCID ID 0000-0001-9928-6448
Phone +39 (0)3927667467
Email giuseppe.dibuono@unipa.it

Study information

Study designInterventional single-centre study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleFeasibility and safety of laparoscopic complete mesocolic excision (CME) for right-sided colon cancer: a prospective clinical study
Study acronymLaCoMEStaR
Study objectivesLaparoscopic complete mesocolic excision (CME) provides better surgical specimens than standard laparoscopic hemicolectomy.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRight-sided colon cancer
InterventionMethod of randomisation: cluster randomisation:
CME group (cases): laparoscopic complete mesocolic excision and central vascular ligation
NCME group (controls): standard laparoscopic right hemicolectomy

Follow-up: variable from short-term follow-up during hospital stay or 30-days in order to obtain feasibility and safety of laparoscopic CME versus NCME; long-term follow-up in order to obtain results about oncological outcomes.
Intervention typeProcedure/Surgery
Primary outcome measure1. Operative time (skin-to-skin) in minutes, measured from medical records at the time of surgery
2. Intraoperative blood loss in mL, measured from medical records at the time of surgery
3. Other intraoperative complications: YES or NO and type of intraoperative complications (categorical variable), measured from medical records at the time of surgery
4. Conversion rate: YES or NO and percentage, measured from medical records at the time of surgery
5. Anastomotic leakage rate: YES or NO and percentage, measured from medical records during hospital stay
6. Specimen length: length in cm of surgical specimen, from histologic examination during 30 days
7. Lymph nodes harvesting: number of lymph nodes in surgical specimen, from histologic examination during 30 days
Secondary outcome measuresPostoperative overall complications: YES or NO and type of postoperative complications (categorical variable), measured from medical records and radiologic imaging during hospital stay or 30 days
Overall study start date01/10/2014
Completion date31/12/2022

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Total final enrolment132
Key inclusion criteriaPatients with right-sided colon cancer
Key exclusion criteriaOpen surgery, right colon resections for inflammatory bowel diseases (IBD) and associated major surgical procedures
Date of first enrolment01/01/2015
Date of final enrolment31/12/2019

Locations

Countries of recruitment

  • Italy

Study participating centre

General and Emergency Surgery - University Hospital Policlinico "P. Giaccone"
via L. Giuffrè, 5
Palermo
90127
Italy

Sponsor information

Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo
Hospital/treatment centre

via del vespro, 129
Palermo
90127
Italy

Phone +39 (0)916552601
Email antonino.agrusa@unipa.it
Website http://www.policlinico.pa.it/portal/
ROR logo "ROR" https://ror.org/05p21z194

Funders

Funder type

University/education

Università degli Studi di Palermo
Government organisation / Local government
Alternative name(s)
Palermo University, University of Palermo
Location
Italy

Results and Publications

Intention to publish date30/05/2020
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2021 11/08/2021 Yes No

Editorial Notes

11/08/2021: Publication reference added.
06/04/2020: Trial's existence confirmed by University Hospital Policlinico "P. Giaccone" of Palermo.